Settaf A, Gugenheim J, Lahlou M K, Gigou M, Capron-Laudereau M, Charpentier B, Reynes M, Lokiec F, Bismuth H
Groupe de Recherche de Chirurgie Hépatique, Hôpital Paul Brousse, Villejuif.
J Chir (Paris). 1989 Aug-Sep;126(8-9):431-7.
52 orthotopic liver transplants were performed in DA to lewis rat strain combination, in order to appreciate cyclosporine toxicity, and efficacy at doses of 10 mg/kg day (G II) and 20 mg/kg/day (GIII) compared to liver allografts in DA/lewis rats. The first signs of cyclosporine hepatotoxicity are biological (increased plasma level of bilirubine and transaminase) that were noticed at the dose of 20 mg/kg/day. Histological signs (cells inclusion, hepatocytic necrosis) appeared late and were less constant as well as difficult to assert creatinine plasma level was the best reflect of cyclosporine nephrotoxicity. Renal toxicity was practically constant at the dose of 20 mg/kg/day. In spite of renal and hepatic toxicity, cyclosporin by itself, allows the abolition of the acute rejection of liver allografts in the rat.
为了评估环孢素的毒性和疗效,对DA到Lewis大鼠品系组合进行了52例原位肝移植,与DA/Lewis大鼠的肝同种异体移植相比,环孢素剂量为10mg/kg/天(G II组)和20mg/kg/天(GIII组)。环孢素肝毒性的最初迹象是生物学指标(胆红素和转氨酶血浆水平升高),在20mg/kg/天的剂量下被观察到。组织学迹象(细胞包涵体、肝细胞坏死)出现较晚,且不太稳定,同时难以确定肌酐血浆水平是环孢素肾毒性的最佳反映。肾毒性在20mg/kg/天的剂量下几乎是恒定的。尽管存在肾毒性和肝毒性,但环孢素本身可消除大鼠肝同种异体移植的急性排斥反应。